The mitochondrial NAD kinase functions as a major metabolic regulator upon increased energy demand.

OBJECTIVE: The mitochondrial nicotinamide adenine dinucleotide (NAD) kinase (MNADK) mediates de novo mitochondrial NADP biosynthesis by catalyzing the phosphorylation of NAD to yield NADP. In this study, we investigated the function and mechanistic basis by which MNADK regulates metabolic homeostasis. METHODS: Generalized gene set analysis by aggregating human patient genomic databases, metabolic studies with genetically engineered animal models, mitochondrial bioenergetic analysis, as well as gain- and loss- of-function studies were performed to address the functions and mechanistic basis by which MNADK regulates energy metabolism and redox state associated with metabolic disease. RESULTS: Human MNADK common gene variants or decreased expression of the gene are significantly associated with the occurrence of type-2 diabetes, non-alcoholic fatty liver disease (NAFLD), or hepatocellular carcinoma (HCC). Ablation of the MNADK gene in mice led to decreased fat oxidation, coincident with increased respiratory exchange ratio (RER) and decreased energy expenditure upon energy demand triggered by endurance exercise or fasting. On an atherogenic high-fat diet (HFD), MNADK-null mice exhibited hepatic insulin resistance and glucose intolerance, indicating a type-2 diabetes-like phenotype in the absence of MNADK. MNADK deficiency led to a decrease in mitochondrial NADP(H) but an increase in cellular reactive oxygen species (ROS) in mouse livers. Consistently, protein levels of the major metabolic regulators or enzymes were decreased, while their acetylation modifications were increased in the livers of MNADK-null mice. Feeding mice with a HFD caused S-nitrosylation (SNO) modification, a posttranslational modification that represses protein activities, on MNADK protein in the liver. Reconstitution of an SNO-resistant MNADK variant, MNADK-S193, into MNADK-null mice mitigated hepatic steatosis induced by HFD. CONCLUSION: MNADK, the only known mammalian mitochondrial NAD kinase, plays important roles in preserving energy homeostasis to mitigate the risk of metabolic disorders.

Evaluation of developmental toxicity and genotoxicity of aqueous seed extract of Croton tiglium L. using zebrafish.

Croton tiglium L. has been used in Ayurvedic and Chinese herbal medicinal formulations from ancient times. Although its seeds are widely prescribed as traditional medicine, there is a dearth of information, regarding its toxic effects, and the mechanisms underlying its toxicity. This study aims to investigate the developmental toxicity and genotoxicity of the aqueous seed extract of C. tiglium L. (AECT) in zebrafish. We have examined the effects of AECT on the early embryonic development of zebrafish. Zebrafish embryos, treated with different concentrations of the AECT, suffered embryonic lethality and displayed various developmental defects. The 96 h-LC50 of AECT was found to be 162.78 µg/ml. Interestingly, the developmental abnormalities observed, such as pericardial edema (PE), yolk sac edema (YSE), spinal curvature (SC), and delayed hatching, varied in severity, in a dose-dependent manner. Zebrafish embryos, treated with different concentrations of AECT, exhibited exaggerated cell death in the anatomical regions of brain, heart, and trunk. Our data suggest that the phenomenon of apoptosis is probably responsible for both embryonic lethality and developmental toxicity in zebrafish embryos. Furthermore, the genotoxic potential of the AECT, in vivo, was evaluated using micronucleus assay and comet assay, on the peripheral blood of zebrafish. The results suggest that AECT has the potential to cause genotoxicity in the peripheral blood of zebrafish.